Wall Street's top marijuana analyst likes Marlboro maker Altria's $1.8 billion investment in Canadian pot company Cronos Group, telling clients the move represents a "unique entry into cannabis."
from Finance https://ift.tt/2zOpBVq
via IFTTT
from Finance https://ift.tt/2zOpBVq
via IFTTT
Kommentare
Kommentar veröffentlichen